Target intelligence / Profile preview

Inflammatory and Oxidative Stress Pathway Targets

Molecular classification
Other, Enzyme, Transcription factor, Receptor
01

Overview

The phrase “Inflammatory and Oxidative Stress Pathway Targets” describes a set of biological signaling mechanisms regulating the generation and resolution of inflammation and reactive oxygen species (ROS). These pathways are essential for cellular defense, tissue repair, immune regulation, and adaptation to injury, but chronic activation or dysregulation contributes to a wide range of diseases, including cancer, cardiovascular and neurodegenerative disorders. Mechanisms include key molecular players such as NF-κB, Nrf2, NADPH oxidase, heme oxygenase-1, and p53, which serve as nodes for pharmacological intervention. Therapeutic strategies focus on modulating these components through antioxidants, inhibitors, or pathway-specific drugs, but clinical translation remains challenging due to pathway complexity and limitations in efficacy and safety.

Other names
Oxidative stress pathwaysInflammatory signaling pathwaysRedox signaling pathways
02

Mechanism of action

Mechanism of action involves inhibition of ROS-generating enzymes (e.g., NADPH oxidase inhibition), enhancement of antioxidant defense (e.g., activation of Nrf2), suppression of pro-inflammatory gene expression (e.g., inhibition of NF-κB pathway), and modulation of mitochondrial function.

03

Biological functions

Signal transductionCell cycle regulationApoptosisImmune responseCell proliferationCell deathMetabolic regulation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesChronic kidney disease
05

Safety considerations

Broad antioxidant supplementation may interfere with normal cell signaling or treatment efficacyOff-target effects due to pathway redundancy and complexityRisk of immunosuppression or cancer promotion if inflammation is excessively blocked
06

Interacting drugs

Antioxidants (e.g., N-acetylcysteine, vitamin E, garlic-derived S-allyl cysteine)

3 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Glutathione (GSH) and GSH/GSSG ratioMalondialdehyde (MDA)8-hydroxy-2’-deoxyguanosine (8-OHdG)SOD (superoxide dismutase) activityNitric oxide levels

Beyond the preview

Go deeper on Inflammatory and Oxidative Stress Pathway Targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory and Oxidative Stress Pathway Targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call